The exclusion criteria were as follows: age < 18 years, HbA1c < 7.0% or >10% at screening, diabetes other than T2DM, or <6 mo on basal insulin treatment together with OADs and SMPG. This evidence concerns the gene INS and type 2 diabetes mellitus.